STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 90 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 11.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,251,000 | +17.9% | 965,245 | +15.6% | 3.69% | -8.1% |
| Q3 2019 | $8,695,000 | -23.7% | 835,245 | +12.2% | 4.02% | -5.0% |
| Q2 2019 | $11,402,000 | +11.4% | 744,245 | -6.5% | 4.23% | +11.9% |
| Q1 2019 | $10,232,000 | +134.4% | 796,245 | +35.9% | 3.78% | +39.5% |
| Q4 2018 | $4,366,000 | -41.5% | 585,930 | 0.0% | 2.71% | -23.6% |
| Q3 2018 | $7,459,000 | -5.1% | 585,930 | +18.9% | 3.54% | +17.4% |
| Q2 2018 | $7,862,000 | +4.6% | 492,930 | 0.0% | 3.02% | +3.0% |
| Q1 2018 | $7,517,000 | -2.2% | 492,930 | 0.0% | 2.93% | +8.2% |
| Q4 2017 | $7,690,000 | +278.6% | 492,930 | +169.5% | 2.71% | +242.7% |
| Q3 2017 | $2,031,000 | -51.3% | 182,930 | -59.6% | 0.79% | -50.1% |
| Q2 2017 | $4,168,000 | +48.6% | 453,000 | +37.3% | 1.58% | +47.5% |
| Q1 2017 | $2,805,000 | – | 330,000 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 475,200 | $6,877,000 | 3.03% |
| Avoro Capital Advisors LLC | 475,000 | $6,873,000 | 2.64% |
| VHCP Management, LLC | 451,400 | $6,532,000 | 1.50% |
| Sio Capital Management, LLC | 140,000 | $2,026,000 | 1.15% |
| Opus Point Partners Management, LLC | 75,000 | $1,085,000 | 0.91% |
| Eventide Asset Management | 620,200 | $8,974,000 | 0.68% |
| Telemetry Investments, L.L.C. | 55,000 | $796,000 | 0.44% |
| Healthcare Value Capital, LLC | 25,000 | $362,000 | 0.40% |
| TFS CAPITAL LLC | 259,916 | $3,761,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 672,562 | $9,732,000 | 0.14% |